Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

A delay of just two seconds can be all it takes for a potential customer to leave your site and choose a competitor’s faster alternative. In 2025, website speed is no longer a mere convenience, it’s a ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...